Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the province of Quebec has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to their publicly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback